Their market share has been declining as the patents available to all countries around the world have expired。
A hard battle is about to take place in china, after a record of world medicine, and a 270,000-day prescription of the blue pill, “viaco” (vanco, achilles) on the seventh week of the united states market。
On 2 september, baek yunshan (600332. Sh), a company listed under the banner of guangzhou medical group ltd. (hereinafter referred to as the guangzhou drug group) and claiming that it “waiting to have a neck long”, finally took over three months after the expiration of van eko's patent, the first chinese edition of the “vieco”-kingo “associate certificate”。
“the application for the registration of raw materials and tablets for the production of the `assisted west' (note: the main active ingredient of jingo and huan aikko) declared by the company has been approved by the national directorate of food and drug control, with the approval of the `national medicines standard h20143277' and `national medicines standard h20143255'.” the head of the guang dynamite group, who obtained china's first license for viagra, said to china's economic weekly, “the ‘kingo’ is a powerful breed created by the guang dynamite group, which looks like a golden egg and believes that it will become a new profit point for white cloud mountain.”
"the little blue pill."
I've contributed over a billion dollars to pfizer
In a note sent to the chinese economic journal, baek yunshan expressed confidence that “kingo” would be the strongest enemy in china on the market for anti-ed drugs。
Van ike, english name viagra. The synthesizing term is the combination of vigor, which means energy, and niagara falls, which is famous。
Oral drugs for treatment and improvement of men's erection functional disorders (known as ed) as the global front, by the world pharmaceutical giant america
Pfizer china told the chinese economic weekly that more than 50 million ike prescriptions had been issued globally. The data show that more than 300 million pieces of “blue pills” have been sold globally to help restore physiological function to tens of millions of ed patients。
Interestingly, such a small “change the world” pill was not originally developed as an anti-ed drug. Nick tred, one of the inventors of the van eico, described pfizer as the first to introduce the acidic westland as a drug for cardiovascular disease into clinical research, but in the experiment, male participants were found to have a longer and stronger body than to return the drug. As a result, pfizer adapted its drug research and development perspective and finally introduced the company's most famous star product。
Van eyke's back is under attack
In fact, huan aik, who is “intentionally in the shadow of willows,” has in recent years become less than a smirk in china’s “vieco” market, and has become a serious threat to the “yellow little pills” in the united states under the banner of ‘little drugs’。
According to data provided to china's economic weekly, since its approval in 2002, hilary has treated more than 39 million patients worldwide, generating more than $10 billion in sales. The total global sales of hilary in 2013 had exceeded $2 billion and had become one of the main growth drivers for companies。
Although pfizer china has indicated that manoe’s sales have been growing in china, van eico has experienced a marked lack of backlash compared to the growth rate of hilary. According to the relevant data, healy's sales in china exceeded 200 million last year, with an increase of 68 million yuan yuan, representing an increase of 45 per cent, compared with only 3 per cent in van eico last year。
Relai china states that since the second quarter of 2013, the market share of healy in the hospital channel has exceeded van ike in its entirety, while in retail outlets, heaile has already had market shares in shenzhen, chengdu, nanjing, beijing and other five cities。
“heili has now worked well with more than 500 retailers in 44 of the country's 23 provinces. We will continue to expand the distribution of retail terminals, develop the three- and four-line cities around the centre and increase the coverage of healy.” in china, yilai told the chinese economic journal that the current ratio of heili's sales to retail and hospital outlets is about 3:1; it is expected to reach 4:1 in the coming years。
There's a strong front, there's a chase. In addition to coping with the tremendous pressure from the rivals, alec has had to face the dilemma of patent expiration and drug-smuggling。
[contributions]
According to a report from the website of the national directorate of food and drug control, in addition to baek yunshan's production permits, journalists have been able to report on the situation
Sooner or later, viagra will drop the price
According to the world health organization, about 10 per cent of men worldwide suffer from ailmental disorders. On this basis, the market capacity ranges from $60 billion to $100 billion. Research from national securities shows that china has about 140 million ed patients and that ed formal treatment drugs are currently only 1 billion yuan in size and potential markets are 10 billion yuan in size。
Although the price of “gingo” has never been disclosed in the area of generic medicines, market rumours suggest that it will be in the range of 50 yuan. This price is competitive compared to vanco of $128 per film。
Paek yunshan told the china economic journal that, according to the overall strategic plan of baek yunshan for the pharmaceutical components of the raw materials, future “kingo” raw materials would not only be used for their own “kingo” formulations, but would also become suppliers of raw materials to other “vieg” producers around the world. It is known that bakunshan is currently forming a sales team to carry out the first stages of overall strategic layout, market research and capacity preparation。
In the face of the "kingo" that came from the horse shoot, pfizer seemed very calm. Pfizer china stated to the china economic weekly that the company currently had no notice of a strategic adjustment for huan eik。
“in the case of the original research plant, it is normal for the patent to expire. Pfizer has entered the chinese market with more than 50 medicines, and van ike's high profile does not represent a significant share of company revenues, so the expiry of van ike patent does not have a significant impact on pfizer china.” pfizer, director-general of business communications of china, zaiqing, said that the future sale of van eico remains optimistic in terms of the subsequent market performance of the company’s other patented drugs。
“as the competition is not yet officially available, pfizer can also insist that the price of van aide is not reduced, but in fact it is observing changes in the market.” according to one of the industry sources, china economics weekly, “since the raw materials and preparations of `kingo' are produced by baek yunshan itself, they can be seamlessly linked to the industrial chain, the future of `kingo' will certainly be more price-driven. And it appears from the situation after the expiration of the patents of other countries, that pfizer will sooner or later reduce the price in order to hold the position.”
According to public data, in 2012, on the first day of the lapse of patent protection in korea, nearly 30 generic drugs were available on the market, which were sold at only one third of the price of the product. As a result of the powerful impact of these drugs, the volume of the sale of van eko fell sharply to 43 per cent that month。
It has been reported that, as a result of generic drugs, vanay has now been reduced by 30 per cent in thailand. In may of this year, the australian drug chain chemistwarehouse also introduced a minimum of $13. 99 in four pieces of alaco, each equivalent to only $20。
Responsible editor: nf043
Responsible editor: zhang dei
[whispering information cellular client downloading]
